Published in J Virol on April 01, 2000
Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med (2005) 2.16
Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment. J Virol (2001) 1.90
Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system. J Virol (2002) 1.52
Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. J Clin Microbiol (2004) 1.26
Sequence diversity of hepatitis C virus: implications for immune control and therapy. World J Gastroenterol (2007) 1.21
Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection. J Virol (2010) 1.18
Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol (2005) 1.10
Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence. Immunol Res (2010) 1.10
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol (2001) 1.08
Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host. J Virol (2012) 1.02
Immunoglobulin allotypes influence IgG antibody responses to hepatitis C virus envelope proteins E1 and E2. Hum Immunol (2008) 0.97
Hepatitis C virus evasion mechanisms from neutralizing antibodies. Viruses (2011) 0.93
Evolution of a cell culture-derived genotype 1a hepatitis C virus (H77S.2) during persistent infection with chronic hepatitis in a chimpanzee. J Virol (2014) 0.93
Transmission of clonal hepatitis C virus genomes reveals the dominant but transitory role of CD8⁺ T cells in early viral evolution. J Virol (2011) 0.93
Evaluation of accumulation of hepatitis C virus mutations in a chronically infected chimpanzee: comparison of the core, E1, HVR1, and NS5b regions. J Virol (2001) 0.90
Genetic divergence of hepatitis C virus: the role of HIV-related immunosuppression. J Acquir Immune Defic Syndr (2008) 0.85
Hepatitis C hypervariable region 1: association of reduced selection pressure in african americans with treatment failure. Dig Dis Sci (2007) 0.75
Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol (1986) 36.06
Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A (1991) 14.05
Selforganization of matter and the evolution of biological macromolecules. Naturwissenschaften (1971) 13.09
Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep (1998) 12.78
Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature (1991) 10.85
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infection. Science (1996) 7.73
The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
Rapid evolution of RNA viruses. Annu Rev Microbiol (1987) 5.97
Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med (1995) 5.55
Nucleotide sequence heterogeneity of an RNA phage population. Cell (1978) 5.55
Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci U S A (1991) 5.51
Lack of protective immunity against reinfection with hepatitis C virus. Science (1992) 4.94
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med (1999) 4.93
Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci U S A (1996) 4.82
A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med (1991) 4.79
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A (1992) 4.47
Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis (1981) 4.15
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology (1999) 4.11
Hepatitis C: global prevalence. Wkly Epidemiol Rec (1997) 3.95
The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42
Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: variability and stability. Virology (1992) 3.22
Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol (1994) 3.06
Running the gamut of retroviral variation. Trends Microbiol (1996) 2.97
Transmissible agent in non-A, non-B hepatitis. Lancet (1978) 2.78
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol (1997) 2.55
Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology (1995) 2.25
Virus 'quasispecies': making a mountain out of a molehill? J Gen Virol (1997) 2.07
Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci U S A (1990) 2.04
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol (1999) 1.98
Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol (1999) 1.93
Characteristics of nucleotide substitution in the hepatitis C virus genome: constraints on sequence change in coding regions at both ends of the genome. J Mol Evol (1997) 1.88
A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology (1996) 1.70
Marked sequence diversity in the putative envelope proteins of hepatitis C viruses. Virus Res (1992) 1.68
Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol (1995) 1.63
Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. J Virol (1994) 1.57
Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs. J Clin Microbiol (1998) 1.53
Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol (1998) 1.48
Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol (1998) 1.41
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol (1999) 1.40
Detection of widespread hepatocyte infection in chronic hepatitis C. Hepatology (1998) 1.39
Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients. Hepatology (1998) 1.33
Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients. J Virol (1996) 1.31
Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy. J Virol (1999) 1.26
Transmission of hepatitis C virus infection to tree shrews. Virology (1998) 1.14
Comparison of two quantitative hepatitis C virus reverse transcriptase PCR assays. J Clin Microbiol (1996) 1.09
Immunity in chimpanzees chronically infected with hepatitis C virus: role of minor quasispecies in reinfection. J Virol (1998) 1.09
Effect of immunosuppression on composition of quasispecies population of hepatitis C virus in patients with chronic hepatitis C coinfected with human immunodeficiency virus. J Hepatol (1997) 1.05
Decreased diversity of hepatitis C virus quasispecies during bone marrow transplantation. J Med Virol (1999) 0.95
Evaluation of Two Methods for Quantitation of Hepatitis C Virus RNA. Mol Diagn (1997) 0.84
The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA (2000) 7.65
Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell (1984) 5.81
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med (2000) 4.83
Glanders in a military research microbiologist. N Engl J Med (2001) 4.77
Induction of nuclear transport with a synthetic peptide homologous to the SV40 T antigen transport signal. Cell (1986) 4.56
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol (2001) 4.22
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology (1999) 4.11
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 3.68
Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. J Virol (2000) 3.26
Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int (2007) 3.09
Genetic epidemiology of hepatitis C virus throughout egypt. J Infect Dis (2000) 3.01
Measuring cerebral blood flow using magnetic resonance imaging techniques. J Cereb Blood Flow Metab (1999) 2.98
The effects of variations in the number and sequence of targeting signals on nuclear uptake. J Cell Biol (1988) 2.89
Adaptive pressure support servo-ventilation: a novel treatment for Cheyne-Stokes respiration in heart failure. Am J Respir Crit Care Med (2001) 2.72
Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol (1997) 2.55
Past adult lead exposure is linked to neurodegeneration measured by brain MRI. Neurology (2006) 2.52
Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis (2001) 2.47
Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate. J Clin Oncol (1983) 2.35
Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. Am J Pathol (1998) 2.19
RNA-protein interactions: involvement of NS3, NS5, and 3' noncoding regions of Japanese encephalitis virus genomic RNA. J Virol (1997) 2.12
Hepatitis E: an emerging infectious disease. Epidemiol Rev (1999) 2.04
Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy. J Virol (1999) 1.98
Identification of four nuclear transport signal-binding proteins that interact with diverse transport signals. Mol Cell Biol (1989) 1.97
Reconstruction of two-dimensional permittivity distribution using the distorted Born iterative method. IEEE Trans Med Imaging (1990) 1.95
Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology (2001) 1.94
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nat Neurosci (2000) 1.93
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke. Eur Respir J (2001) 1.90
Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis (2000) 1.87
Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med (2000) 1.81
Mechanism of cellulose synthesis in Agrobacterium tumefaciens. J Bacteriol (1995) 1.80
Chronic viral hepatitis and the human genome. Hepatology (2000) 1.79
Cloned hepatitis delta virus cDNA is infectious in the chimpanzee. J Virol (1989) 1.75
Syphilis serology in human immunodeficiency virus infection: evidence for false-negative fluorescent treponemal testing. J Infect Dis (1997) 1.74
Characterization and expression of the complementary DNA encoding rat histidine decarboxylase. Proc Natl Acad Sci U S A (1990) 1.66
Role of the large hepatitis B virus envelope protein in infectivity of the hepatitis delta virion. J Virol (1993) 1.65
Carboxy-terminal truncations of the HBV core protein affect capsid formation and the apparent size of encapsidated HBV RNA. Virology (1993) 1.62
Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology (1979) 1.61
Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. J Neurosci (1999) 1.59
Vaccines to prevent viral hepatitis. N Engl J Med (1997) 1.58
Expression of alveolar macrophage adhesion molecules in pulmonary sarcoidosis. Chest (1992) 1.54
Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs. J Clin Microbiol (1998) 1.53
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem (1994) 1.51
Class II HLA alleles and hepatitis B virus persistence in African Americans. J Infect Dis (1999) 1.48
Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol (1998) 1.48
Crystal structure of tandem type III fibronectin domains from Drosophila neuroglian at 2.0 A. Neuron (1994) 1.46
Development of a high-resolution fat and CSF-suppressed optic nerve DTI protocol at 3T: application in multiple sclerosis. Funct Neurol (2013) 1.46
Using tests for recent infection to estimate incidence: problems and prospects for HIV. Euro Surveill (2010) 1.45
Production of infectious hepatitis delta virus in vitro and neutralization with antibodies directed against hepatitis B virus pre-S antigens. J Virol (1992) 1.45
Cyclic appearance of defective interfering particles of herpes simplex virus and the concomitant accumulation of early polypeptide VP175. Intervirology (1975) 1.40
Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol (1999) 1.40
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices. J Viral Hepat (2013) 1.37
Association between Ser311Cys polymorphism in the dopamine D2 receptor gene and schizophrenia risk: a meta-analysis in Asian populations. Genet Mol Res (2012) 1.37
Factors associated with interest in initiating treatment for hepatitis C Virus (HCV) infection among young HCV-infected injection drug users. Clin Infect Dis (2005) 1.35
Nutritional significance of fructose and sugar alcohols. Annu Rev Nutr (1981) 1.34
Detection of diverse hepatitis C virus (HCV)-specific cytotoxic T lymphocytes in peripheral blood of infected persons by screening for responses to all translated proteins of HCV. J Virol (2001) 1.34
High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. Br J Radiol (2003) 1.32
Determinants of the quantity of hepatitis C virus RNA. J Infect Dis (2000) 1.32
Differential ability of a T-antigen transport-defective mutant of simian virus 40 to transform primary and established rodent cells. Mol Cell Biol (1985) 1.30
Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors. Brain Res (1999) 1.29
Antigenic and immunogenic characteristics of nuclear and membrane-associated simian virus 40 tumor antigen. J Virol (1980) 1.26
Poor performance of hepatitis C antibody tests in hospital patients in Uganda. J Med Virol (2010) 1.25
The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol (2001) 1.25
Anti-idiotypic antibody vaccine for type B viral hepatitis in chimpanzees. Science (1986) 1.24
Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J Virol (2000) 1.24
Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. J Neurochem (1998) 1.23
Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene. Am J Hum Genet (2000) 1.23
Tissue culture system for infection with human hepatitis delta virus. J Virol (1991) 1.21
Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol (2000) 1.21
Differential phosphorylation of cytoplasmic and nuclear variants of simian virus 40 large T antigen encoded by simian virus 40-adenovirus 7 hybrid viruses. J Virol (1984) 1.21
Single nucleotide polymorphisms and haplotypes in the IL10 region associated with HCV clearance. Genes Immun (2005) 1.21
The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci (1999) 1.18
Generation of transmissible hepatitis C virions from a molecular clone in chimpanzees. Virology (1999) 1.18
Intracellular transport of SV40 large tumor antigen: a mutation which abolishes migration to the nucleus does not prevent association with the cell surface. Virology (1982) 1.17
Sleep-disordered breathing among patients with first-ever stroke. J Neurol (2000) 1.17
The cytoplasmic domain of the Drosophila cell adhesion molecule neuroglian is not essential for its homophilic adhesive properties in S2 cells. J Biol Chem (1995) 1.17
What husbands in northern India know about reproductive health: correlates of knowledge about pregnancy and maternal and sexual health. J Biosoc Sci (2000) 1.15
Enzyme-linked immunosorbent assay using Mycobacterium tuberculosis antigen 5 for the diagnosis of pulmonary tuberculosis in China. Am Rev Respir Dis (1986) 1.15
Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm Infect (2008) 1.14
The chimpanzee model of hepatitis C virus infections. ILAR J (2001) 1.13
Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.13
Biochemical characterization of nuclear and cytoplasmic forms of SV40 tumor antigens encoded by parental and transport-detective mutant SV40-adenovirus 7 hybrid viruses. Virology (1980) 1.12
GB virus B as a model for hepatitis C virus. ILAR J (2001) 1.12
The structure of the multidrug resistance protein 1 (MRP1/ABCC1). crystallization and single-particle analysis. J Biol Chem (2001) 1.11
Defining the pathway for Tat-mediated delivery of beta-glucuronidase in cultured cells and MPS VII mice. Mol Ther (2005) 1.10
Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium. J Virol (2000) 1.10
An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes. Gene Ther (2008) 1.09
Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice. Pharmacol Biochem Behav (1999) 1.09
In vitro propagation and production of hepatitis E virus from in vivo-infected primary macaque hepatocytes. Virology (1996) 1.09
Human immunodeficiency virus seroconversion and evolution of the hepatitis C virus quasispecies. J Virol (2001) 1.08
Early changes in water diffusion, perfusion, T1, and T2 during focal cerebral ischemia in the rat studied at 8.5 T. Magn Reson Med (1999) 1.08
Occult hepatitis B viral DNA in liver carcinomas from a region with a low prevalence of chronic hepatitis B infection. J Viral Hepat (2004) 1.07
High seroprevalence of hepatitis C infection among risk groups in Egypt. Am J Trop Med Hyg (1994) 1.07
Extent and pattern of DNA methylation alteration in rice lines derived from introgressive hybridization of rice and Zizania latifolia Griseb. Theor Appl Genet (2006) 1.06
Modulation of multidrug resistance protein 1 (MRP1/ABCC1) transport and atpase activities by interaction with dietary flavonoids. Mol Pharmacol (2001) 1.06